Thursday, May 2, 2019
City Flats Hotel
83 Monroe Center St NW, Grand Rapids, MI
4:00 pm - 7:30 pm
General overview of industrial hemp plant and cannabidiol (CBD) market, preliminary research on cannabidiol and potential applications specific to skin health, and current regulations.
James Baumgartner, Ph.D.
President, Panacea Life Sciences
James brings over 25 years of drug discovery experience to table which reinforces the company’s commitment to its foundation in scientific research and development in the healthcare and biotech industries. He is an innovative business leader who combines his acute business acumen with his broad scientific excellence. James has expertise in drug discovery and development which lead him assisting in over 700 biotechnology and pharmaceutical companies to reach unparalleled levels of success, especially in the area of advancing projects to IND filing. James has a BS in Biochemistry from UC Davis and a Ph.D. in Biochemistry and Pharmacology from Washington State University.
The 2018 farm bill has legalized products derived from the industrial hemp plant which has spawned a new industry expected to eclipse 25 billion dollars in United States retail sales by 2022. Because the industrial hemp plant, Cannabis sativa (L) has been kept in the dark due to prior DEA schedule 1 designation, there is much that the scientific and medical communities are just beginning to learn about the plant and its application to human and animal health. The industrial hemp plant, and one of its major cannabinoids Cannabidiol (CBD), may be one of the richest sources for new human health supplements discovered in our lifetime. CBD has been reported through anecdotal information to address over 100 human conditions ranging from acne to cancer. While the potential to develop novel medications, supplements and beauty products are immense, the regulations on how to commercialize products are emerging on a daily basis. In this discussion, we will provide an overview of the industrial hemp plant and cannabidiol, share information on preliminary research on cannabidiol, potential applications specific to skin health, and briefly address current regulations.
CBD, Cannabis, and Hemp Beauty - Worth the Hype?
Report Analyst - Mintel
Alison is an Analyst for Mintel's US Beauty and Personal Care Reports. Prior to joining Mintel in 2015, Alison spent four years as an educator for a leading beauty retailer and a global research analyst in CPG. Alison's presentation will dive into the confusion surrounding cannabis beauty, its efficacy, and the various methods marketers use to promote these ingredients.
|3:00 - 4:00 pm||Board Meeting (open for board members and committee volunteers)|
|4:00 - 4:45 pm||
Registration and Reception
|4:45 - 5:30 pm||Speaker 1 - James Baumgartner, Ph.D.|
|5:30 - 6:15 pm||Speaker 2 - Alison Gaither|
|6:15 - 7:30 pm||Dinner|
REGISTRATION IS NOW OPEN!
|Thursday, September 19||Presentations and Golf Outing||TBD|
|Thursday, November 7||Continuing Education Course TBD and Chapter Officer Installation||TBD|